Abstract
You have accessJournal of UrologyRobotics – Benign Disease1 Apr 2016V10-08 COMBINED ROBOTIC ASSISTED BLADDER DIVERTICULECTOMY AND PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE Jed-Sian Cheng, Mahdi Zangi, and Shahin Tabatabaei Jed-Sian ChengJed-Sian Cheng More articles by this author , Mahdi ZangiMahdi Zangi More articles by this author , and Shahin TabatabaeiShahin Tabatabaei More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.1588AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The standard management of large bladder diverticula (BD) with bladder outlet obstruction (BOO) is open surgery, but recent reports describe a robotic approach for diverticulectomy. However, robotic management of BOO in small prostates is technically difficult. Therefore, we describe a novel combination of photoselective vaporization of the prostate (PVP), and robotic assisted bladder diverticulectomy (RABD) for BD. METHODS Prior to RABD or at the same time as RABD, a PVP was performed transurethrally to the prostate capsule. Ureteral stents are placed if BD was close to the ureteral orifice. At the conclusion of RABD, the peritoneum is repaired so the bladder is in the retroperitoneal position. A cystogram is performed 5-7 days just prior to catheter removal. A retrospective review of PVP and RABD for benign BD was performed identifying patient characteristics, lasing time, joules, operative time, estimated blood loss (EBL), and length of stay (LOS). RESULTS A total of 10 patients underwent both PVP and RABD: 5 with PVP and RABD in separate settings and 5 received PVP and RABD together. The results are summarized in the table below. No significant differences were identified between the PVP performed separately vs. same time as RABD. CONCLUSIONS Combination photoselective vaporization of the prostate (PVP), and robotic assisted bladder diverticulectomy (RABD) for bladder diverticula is an effective treatment regardless of prostate size. This combination can be considered in the same setting with no significant changes in outcome. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e948 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Jed-Sian Cheng More articles by this author Mahdi Zangi More articles by this author Shahin Tabatabaei More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have